Therapies for COVID-19-Related Persistent Olfactory Disorders: One of the Good Fruits of the Pandemic
Journal article published in 2023 by
Sven Saussez 
,
Luigi Angelo Vaira ,
Giacomo De Riu,
Jérome R. Lechien
,
Luigi Angelo Vaira ,
Giacomo De Riu,
Jérome R. Lechien
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
At the beginning of 2021, the scientific community realized the burden of COVID-19-related persistent olfactory disorders (ODs). The percentage of those infected with COVID-19 who developed severe and persistent ODs [1–3] with devastating effects on their quality of life was 5 to 40% [4,5].